ARNT and kidney cancer: To test the relevance of these findings in renal tumours themselves, we next performed HIF-1β ChIP-qPCR analysis of each of the HIF-binding sites that overlapped or interacted with a RCC-susceptibility locus, using primary cultures of tumour and normal cells explanted from a patient with kidney cancer (Fig. 4A–F).